Steinbeis, F.* ; Thibeault, C.* ; Steinbrecher, S.* ; Ahlgrimm, Y.* ; Haack, I.A.* ; August, D.* ; Balzuweit, B.* ; Bellinghausen, C.* ; Berger, S.* ; Chaplinskaya-Sobol, I.* ; Cornely, O.* ; Doeblin, P.* ; Endres, M.* ; Fink, C.* ; Finke, C.* ; Frank, S.* ; Hans, S.* ; Hartung, T.* ; Hellmuth, J.C.* ; Herold, S.* ; Heuschmann, P.* ; Heyckendorf, J.* ; Heyder, R.* ; Hippenstiel, S.* ; Hoffmann, W.* ; Kelle, S.U.* ; Knape, P.* ; Koehler, P.* ; Kretzler, L.* ; Leistner, D.M.* ; Lienau, J.* ; Lorbeer, R.* ; Lorenz-Depiereux, B. ; Lüttke, C.D.* ; Mai, K.* ; Merle, U.* ; Meyer-Arndt, L.A.* ; Miljukov, O.* ; Muenchhoff, M.* ; Müller-Plathe, M.* ; Neuhann, J.* ; Neuhauser, H.* ; Nieters, A.* ; Otte, C.* ; Pape, D.* ; Pinto, R.M.* ; Pley, C.* ; Pudszuhn, A.* ; Reuken, P.* ; Rieg, S.* ; Ritter, P.* ; Rohde, G.* ; Rönnefarth, M.* ; Ruzicka, M.* ; Schaller, J.* ; Schmidt, A.* ; Schmidt, S.* ; Schwachmeyer, V.* ; Schwanitz, G.* ; Seeger, W.* ; Stahl, D.* ; Stobäus, N.* ; Stubbe, H.C.* ; Suttorp, N.* ; Temmesfeld, B.* ; Thun, S.* ; Triller, P.* ; Trinkmann, F.* ; Vadász, I.* ; Valentin, H.* ; Vehreschild, M.* ; von Kalle, C.* ; von Lilienfeld-Toal, M.* ; Weber, J.* ; Welte, T.* ; Wildberg, C.* ; Wizimirski, R.* ; Zvork, S.* ; Sander, L.E.* ; Vehreschild, J.* ; Zöller, T.* ; Kurth, F.* ; Witzenrath, M.*
Analysis of acute COVID-19 including chronic morbidity: Protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP).
Infection:12 (2023)
BACKGROUND: The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic causes a high burden of acute and long-term morbidity and mortality worldwide despite global efforts in containment, prophylaxis, and therapy. With unprecedented speed, the global scientific community has generated pivotal insights into the pathogen and the host response evoked by the infection. However, deeper characterization of the pathophysiology and pathology remains a high priority to reduce morbidity and mortality of coronavirus disease 2019 (COVID-19). METHODS: NAPKON-HAP is a multi-centered prospective observational study with a long-term follow-up phase of up to 36 months post-SARS-CoV-2 infection. It constitutes a central platform for harmonized data and biospecimen for interdisciplinary characterization of acute SARS-CoV-2 infection and long-term outcomes of diverging disease severities of hospitalized patients. RESULTS: Primary outcome measures include clinical scores and quality of life assessment captured during hospitalization and at outpatient follow-up visits to assess acute and chronic morbidity. Secondary measures include results of biomolecular and immunological investigations and assessment of organ-specific involvement during and post-COVID-19 infection. NAPKON-HAP constitutes a national platform to provide accessibility and usability of the comprehensive data and biospecimen collection to global research. CONCLUSION: NAPKON-HAP establishes a platform with standardized high-resolution data and biospecimen collection of hospitalized COVID-19 patients of different disease severities in Germany. With this study, we will add significant scientific insights and provide high-quality data to aid researchers to investigate COVID-19 pathophysiology, pathology, and chronic morbidity.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Covid-19 ; Coronavirus ; Deep Phenotyping ; Infectious Disease ; Sars-cov-2
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2023
Prepublished im Jahr
0
HGF-Berichtsjahr
2023
ISSN (print) / ISBN
0300-8126
e-ISSN
1439-0973
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: ,
Heft: ,
Seiten: ,
Artikelnummer: 12
Supplement: ,
Reihe
Verlag
Urban & Vogel
Verlagsort
Tiergartenstrasse 17, D-69121 Heidelberg, Germany
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504091-004
Förderungen
German Federal Ministry of Education and Research (BMBF)
National Pandemic Cohort Network (NAPKON) is part of the Network University Medicine (NUM)
Projekt DEAL
Copyright
Erfassungsdatum
2023-10-06